Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
Year: 2023
Type: dataset
Source: immuneACCESS
DOI: 10.21417/es2023nm
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4365511037